doxorubicin in chemotherapy

Doxorubicin or adriamycin is most commonly used to treat several types of cancers such as breast cancer, carcinomas, sarcomas and hematological cancers. a growing body of evidence supports the view that this drug can be a double-edge sword. indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of dox and diminishing the quality of patients’ life during and after dox treatment.